Price A, Davies R, Heller S R, Milford-Ward A, Weetman A P
Department of Chemical Pathology, Northern General Hospital, Sheffield, United Kingdom.
J Clin Endocrinol Metab. 1996 Mar;81(3):1160-3. doi: 10.1210/jcem.81.3.8772593.
Gestational thyrotoxicosis is now widely believed to result from excessive thyroidal stimulation by hCG. Our clinical impression has been that this condition is more frequent in Asian women than in those of European origin. To assess this possibility further, we analyzed thyroid hormone levels in the sera of 294 Asian women, obtained as part of a screening program at 15-16 weeks of pregnancy, and compared these with 292 sera from age- and parity-matched European women at a similar time of gestation. TSH levels were significantly lower in the Asian group (P < 0.001). Suppressed TSH levels (< 0.35 mIU/L) were found in 15.7% of Asian women and 4.8% of European women (P < 0.001). In both groups of women with suppressed TSH values, hCG and hCG beta levels were higher than in the women with normal TSH levels. Free T4 levels in the Asian women were significantly higher in those with suppressed TSH (P < 0.001), but this was not found in the European women. There was also a significant increase in the free T3 index in the Asian women with suppressed TSH compared to that in an age-matched group of Asian women with normal TSH levels (P < 0.02), but this was not observed in European women with suppressed TSH. None of the women with suppressed TSH had thyroid-stimulating antibodies. These results show that Asian women more frequently develop biochemical evidence of thyrotoxicosis at the beginning of the second trimester of pregnancy than those of European origin and are, therefore, likely to be at greater risk of clinically apparent gestational thyrotoxicosis and hyperemesis gravidarum. Genetically determined differences in the production or metabolism of hCG isoforms may account for this increased risk.
目前普遍认为,妊娠甲状腺毒症是由人绒毛膜促性腺激素(hCG)对甲状腺的过度刺激所致。我们的临床印象是,亚洲女性患这种疾病的频率高于欧洲裔女性。为了进一步评估这种可能性,我们分析了294名亚洲女性血清中的甲状腺激素水平,这些血清是在妊娠15 - 16周的筛查项目中获得的,并将其与292名年龄和胎次匹配的欧洲女性在相似孕期的血清进行了比较。亚洲组的促甲状腺激素(TSH)水平显著更低(P < 0.001)。在15.7%的亚洲女性和4.8%的欧洲女性中发现TSH水平被抑制(< 0.35 mIU/L)(P < 0.001)。在两组TSH值被抑制的女性中,hCG和hCGβ水平均高于TSH水平正常的女性。TSH被抑制的亚洲女性的游离甲状腺素(Free T4)水平显著更高(P < 0.001),但欧洲女性中未发现这种情况。与年龄匹配的TSH水平正常的亚洲女性组相比,TSH被抑制的亚洲女性的游离三碘甲状腺原氨酸指数(Free T3 index)也显著升高(P < 0.02),但TSH被抑制的欧洲女性中未观察到这种情况。TSH被抑制的女性均未检测到促甲状腺素受体抗体。这些结果表明,与欧洲裔女性相比,亚洲女性在妊娠中期开始时更频繁地出现甲状腺毒症的生化证据,因此,她们可能更易发生临床显性妊娠甲状腺毒症和妊娠剧吐。hCG异构体产生或代谢的遗传决定差异可能是这种风险增加的原因。